

Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, Phexxi™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
We will give women everywhere control of their sexual and reproductive health.
2 dipendenti di Evofem Biosciences hanno esaminato Evofem Biosciences attraverso varie dimensioni della cultura, fornendo le loro opinioni sugli articoli che vanno dai feedback esecutivi al ritmo di lavoro. L'ultima recensione sia stata mesi fa.
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.









Lack of leadership. Very inexperienced.

Dici Evofem Biosciences sei interessato a lavorare presso la società, pur mantenendo la vostra identità personale anonimo. Comparabilmente darà Evofem Biosciences la possibilità di noleggiare you.When c'è un lavoro di apertura che è una misura faremo la partita accadere.
| 50% | Promoters |
|---|---|
| 0% | Passives |
| 50% | Detractors |





Inviare loro un invito a valutare la cultura aziendale.